Compass Therapeutics, Inc. · NASDAQ:CMPX

Mpm Bioimpact LLC reported a 6.20% stake in Compass Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

Mpm Bioimpact LLC reported a 6.20% stake in Compass Therapeutics, Inc., 8,567,896 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
6.20%
Shares
8,567,896
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
MPM BioImpact LLC6.20%8,567,896

Source

View original at SEC

Related